
Before Neon, Kimmy Scotti learned venture capital by making things: jewelry, media, prescription savings and skincare. Her career is a study in following the useful clue, especially when it points somewhere unexpected.
GreyLion courts companies at an awkward threshold: too established to improvise forever, too promising to sell the future for a spreadsheet. Its answer is patient capital, operating discipline and a four-part playbook built for founders who still want a hand on the wheel.
Insight Partners built one of technology’s largest investment platforms by staying narrow on software and going wide on stage. Behind the capital is a less glamorous engine: analysts making calls, operators carrying playbooks, and a network designed to turn introductions into growth.
The New York private equity firm has spent nearly half a century turning sector focus, repeat executives and operational playbooks into a business. Its healthcare record also shows where that model can collide with regulators.
Bluestone Equity Partners is making a focused bet on the businesses around the game - the software, services, venues and experiences that turn attention into durable revenue.
Regal Healthcare Capital Partners has raised nearly $1.3 billion by treating healthcare’s unglamorous details - staffing, scheduling, dashboards and provider incentives - as the machinery of growth.
The New York firm has spent more than two decades in the least cinematic part of company building: turning proven B2B products into durable businesses. Its edge is a patient, research-led playbook for the years after product-market fit.
MidOcean Partners started by buying a $1.8 billion private-equity business from Deutsche Bank. Two decades later, its three-part platform shows how a focused middle-market investor can become a capital shop without trying to become everything to everyone.
The New York firm buys overlooked B2B software businesses, installs operating muscle and stays focused on the unglamorous work of making a good product into a durable company.